Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Engelhard

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|September 1, 1993
Invasive fungal sinusitis in patients undergoing bone marrow transplantationP E Drakos, A Nagler, R Or, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Cycling of peripheral blood and marrow lymphocytes in cyclic neutropeniaD Engelhard, K S Landreth, N Kapoor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Impact of previous aspergillosis on the outcome of bone marrow transplantationF Offner, C Cordonnier, P Ljungman, et al.
Bone Marrow Transplantation|December 2, 2008
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in LeukemiaJ Styczynski, P Reusser, H Einsele, et al.
Bone Marrow Transplantation|March 8, 2005
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMTP Ljungman, D Engelhard, R de la Cámara, et al.
British Journal of Haematology|March 1, 1995
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapseE Naparstek, R Or, A Nagler, et al.
Israel Journal of Medical Sciences|March 1, 1986
New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantationS Slavin, R Or, E Naparstek, et al.
Bone Marrow Transplantation|October 1, 1995
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective studyD Engelhard, H Elishoov, R Or, et al.
Bone Marrow Transplantation|January 1, 1993
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipientsD Engelhard, A Nagler, I Hardan, et al.
Infection|May 9, 2013
Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patientsD Averbuch, E Horwitz, J Strahilevitz, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|September 1, 1993
Invasive fungal sinusitis in patients undergoing bone marrow transplantationP E Drakos, A Nagler, R Or, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Cycling of peripheral blood and marrow lymphocytes in cyclic neutropeniaD Engelhard, K S Landreth, N Kapoor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Impact of previous aspergillosis on the outcome of bone marrow transplantationF Offner, C Cordonnier, P Ljungman, et al.
Bone Marrow Transplantation|December 2, 2008
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in LeukemiaJ Styczynski, P Reusser, H Einsele, et al.
Bone Marrow Transplantation|March 8, 2005
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMTP Ljungman, D Engelhard, R de la Cámara, et al.
British Journal of Haematology|March 1, 1995
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapseE Naparstek, R Or, A Nagler, et al.
Israel Journal of Medical Sciences|March 1, 1986
New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantationS Slavin, R Or, E Naparstek, et al.
Bone Marrow Transplantation|October 1, 1995
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective studyD Engelhard, H Elishoov, R Or, et al.
Bone Marrow Transplantation|January 1, 1993
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipientsD Engelhard, A Nagler, I Hardan, et al.
Infection|May 9, 2013
Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patientsD Averbuch, E Horwitz, J Strahilevitz, et al.
Pageof 10